DAR ES SALAAM, June 1 -- TANZANIA is drawing increased investment into pharmaceutical manufacturing, driven by strong market demand, improved business conditions, and the development of dedicated industrial zones such as the Mloganzila pharmaceutical park.

Deputy Permanent Secretary in the Ministry of Health (Drugs and Medical Supplies), Emmanuel Tayari, made the statement today, June 1, 2026 in Dar es Salaam stating that the government is receiving growing interest from large international firms, including a Shanghai Stock Exchange–listed Chinese company planning to invest in the production of generic medicines.

He said investor confidence is being boosted by available infrastructure, regional market access through the EAC and SA...